NEWS

Russia to Begin Human Trials of AI-Powered Cancer Vaccine in 2025

Published

3 weeks ago

August 5, 2025

Russia is preparing to launch human trials of a groundbreaking cancer vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology—the same institute behind the Sputnik COVID-19 vaccines.

Preclinical studies have reportedly shown that the vaccine can suppress tumor growth and prevent the spread of cancer (metastasis).

The vaccine is uniquely designed for each patient, using artificial intelligence to analyze the genetic makeup of their tumors.

The first human trials, focusing on a melanoma-specific version of the vaccine, are expected to begin in late 2025 at the Hertsen Research Institute and the N.N. Blokhin National Medical Research Center in Moscow.

Discover more from Naijanewstoday

Subscribe to get the latest posts sent to your email.

Related Topics:#ASIWAJUMEDIA #instablog9jaNews #TrendingStory #Awareness #StayUpdated

Up Next

TVC Confirms Morayo Afolabi-Brown’s Resignation After 12 Years as ‘Your View’ Host

Don't Miss

Badeggi FM Defies Shutdown Order, Demands Evidence From Niger Governor

WALE BUSARI

Hi, I’m Babawale Busari — a passionate storyteller, content creator, and observer of the world around me. I share compelling stories, current events, digital trends, and insightful commentary that spark thought and conversation. Whether it’s news, culture, tech, or everyday experiences, I believe every detail matters. Thanks for stopping by — let's explore the world, one post at a time.